Browse by UCL people
Group by: Type | Date
Jump to: Article | Working / discussion paper
Number of items: 13.
Article
Coelewij, L;
Waddington, KE;
Robinson, GA;
Chocano, E;
McDonnell, T;
Farinha, F;
Peng, J;
... Pineda-Torra, I; + view all
(2021)
Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.
Arteriosclerosis, Thrombosis, and Vascular Biology
10.1161/ATVBAHA.120.315321.
(In press).
|
|
Croca, SC;
Griffin, M;
Farinha, F;
Isenberg, DA;
Nicolaides, A;
Rahman, A;
(2021)
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Rheumatology
, 60
(9)
pp. 4185-4198.
10.1093/rheumatology/keaa905.
|
|
Cunha, RN;
Aguiar, R;
Cardoso Farinha, FM;
(2018)
Impact of Pegloticase on Patient Outcomes in Refractory Gout: Current Perspectives.
[Review].
Open Access Rheumatology : Research and Reviews
, 10
pp. 141-149.
10.2147/OARRR.S176951.
|
 |
|
Durao-Carvalho, Goncalo;
Fernandez-Gonzalez, Raquel;
Goulden, Bethan;
Farinha, Filipa;
Isenberg, David;
(2023)
Major determinants of prolonged remission in systemic lupus erythematosus: retrospective study over a 41+year period.
Rheumatology
, 62
(1)
pp. 209-216.
10.1093/rheumatology/keac242.
|
|
Farinha, F;
Rahman, A;
(2024)
Lupus nephritis outcomes – is the picture changing?
ARP Rheumatology
, 3
(1)
pp. 2-3.
|
|
Farinha, F;
Abrol, E;
Isenberg, DA;
(2016)
Biologic therapies in patients with neuropsychiatric systemic lupus erythematosus.
[Letter].
Lupus
, 25
(11)
pp. 1278-1279.
10.1177/0961203316631636.
|
|
|
Farinha, F;
Freitas, F;
Águeda, A;
Cunha, I;
Barcelos, A;
(2017)
Concerns of patients with systemic lupus erythematosus and adherence to therapy – a qualitative study.
Patient Preference and Adherence
, 11
pp. 1213-1219.
10.2147/PPA.S137544.
|
|
|
Farinha, F;
Isenberg, DA;
(2015)
Advances in IFN-alpha targeting-approaches for SLE treatment.
Drugs of the Future
, 40
(9)
p. 129.
10.1358/dof.2015.40.9.2377844.
|
|
Farinha, F;
Pepper, RJ;
Oliveira, DG;
McDonnell, T;
Isenberg, DA;
Rahman, A;
(2020)
Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up.
Rheumatology
10.1093/rheumatology/keaa103.
(In press).
|
|
|
Fehmi, J;
Davies, AJ;
Antonelou, M;
Keddie, S;
Pikkupeura, S;
Querol, L;
Delmont, E;
... Rinaldi, S; + view all
(2023)
Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis.
PLOS ONE
, 18
, Article e0281156. 10.1371/journal.pone.0281156.
|
|
Garelick, D;
Pinto, SM;
Farinha, F;
Pires, T;
Khan, E;
Isenberg, D;
(2021)
Fracture risk in systemic lupus erythematosus patients over 28 years.
Rheumatology
, 60
(6)
pp. 2765-2772.
10.1093/rheumatology/keaa705.
|
|
Gisca, E;
Duarte, L;
Farinha, F;
Isenberg, DA;
(2021)
Assessing outcomes in a lupus nephritis cohort over a 40-year period.
Rheumatology
, 60
(4)
pp. 1814-1822.
10.1093/rheumatology/keaa491.
|
Working / discussion paper
|
Coelewij, L;
Waddington, K;
Robinson, G;
Chocano, E;
McDonnell, T;
Farinha, F;
Peng, J;
... Pineda-Torra, I; + view all
(2020)
Using serum metabolomics analysis to predict sub-clinical atherosclerosis in patients with SLE.
MedRxiv: Cold Spring Harbor, NY, USA.
|
 |
